Aguirre, C; Alonso-Torres, A; Agüera, E; García-Domínguez, JM; Montero-Escribano, P; González-Quintanilla, V; Costa-Frossard, L; Oreja-Guevara, C; Reyes-Garrido, V; Caminero-Rodríguez, AB; Riancho, J; Sánchez, O; Forero, L; Pérez-Parra, F; Ares-Luque, A; Téllez, N; Arzalluz-Luque, J; Iglesias, F; Casado-Ruiz, V; Castellano-Vicente, AJ; Borrega, L; Galán, V; de Antonio, LAR; Romero, C; García-Rodríguez, R; Cano-Orgaz, AT; Sánchez-Menoyo, JL; Pérez-Ruiz, D; Gutiérrez-Martin, F; Hernández-Echevarría, L; Meca-Lallana, V – 2024 – 10.1007/s40261-024-01397-5
Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study – CLINICAL DRUG INVESTIGATION
by prodriguez | Jan 1, 2024 | Publicaciones - C-01 | 0 comments